Advertisement
| clinical practice guidelines for management of schizophrenia: Practice Guideline for the Treatment of Patients with Schizophrenia American Psychiatric Association, 1997 The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. |
| clinical practice guidelines for management of schizophrenia: The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia American Psychiatric Association, 2016 The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. |
| clinical practice guidelines for management of schizophrenia: Psychosis and Schizophrenia in Children and Young People National Collaborating Centre for Mental Health (Great Britain), 2013 These guidelines from NICE set out clear recommendations, based on the best available evidence, for health care professionals on how to work with and implement physical, psychological and service-level interventions for people with various mental health conditions.The book contains the full guidelines that cannot be obtained in print anywhere else. It brings together all of the evidence that led to the recommendations made, detailed explanations of the methodology behind their preparation, plus an overview of the condition covering detection, diagnosis and assessment, and the full range of treatment and care approaches. There is a worse prognosis for psychosis and schizophrenia when onset is in childhood or adolescence, and this new NICE guideline puts much-needed emphasis on early recognition and assessment of possible psychotic symptoms. For the one-third of children and young people who go on to experience severe impairment as a result of psychosis or schizophrenia the guideline also offers comprehensive advice from assessment and treatment of the first episode through to promoting recovery.This guideline reviews the evidence for recognition and management of psychosis and schizophrenia in children and young people across the care pathway, encompassing access to and delivery of services, experience of care, recognition and management of at-risk mental states, psychological and pharmacological interventions, and improving cognition and enhancing engagement with education and employment. |
| clinical practice guidelines for management of schizophrenia: American Psychiatric Association Practice Guidelines American Psychiatric Association, 1996 The aim of the American Psychiatric Association Practice Guideline series is to improve patient care. Guidelines provide a comprehensive synthesis of all available information relevant to the clinical topic. Practice guidelines can be vehicles for educating psychiatrists, other medical and mental health professionals, and the general public about appropriate and inappropriate treatments. The series also will identify those areas in which critical information is lacking and in which research could be expected to improve clinical decisions. The Practice Guidelines are also designed to help those charged with overseeing the utilization and reimbursement of psychiatric services to develop more scientifically based and clinically sensitive criteria. |
| clinical practice guidelines for management of schizophrenia: Clinical Practice Guidelines We Can Trust Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, 2011-06-16 Advances in medical, biomedical and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of clinical practice guidelines and how they can be improved to enhance healthcare quality and patient outcomes. Clinical practice guidelines now are ubiquitous in our healthcare system. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy clinical practice guidelines emphasizing transparency; management of conflict of interest ; systematic review-guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality (AHRQ), as well as various Congressional staff and policymakers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use clinical practice guidelines, consumers, clinicians, and payers. |
| clinical practice guidelines for management of schizophrenia: Pharmacological Treatment of Mental Disorders in Primary Health Care World Health Organization, 2009 This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process. |
| clinical practice guidelines for management of schizophrenia: First Episode Psychosis Katherine J. Aitchison, Robin M. Murray, Patrick J. R. Power, Eva M. Tsapakis, 1999-02-17 The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management. |
| clinical practice guidelines for management of schizophrenia: Treatment–Refractory Schizophrenia Peter F. Buckley, Fiona Gaughran, 2014-03-18 Schizophrenia is often associated with an inadequate response to pharmacological and non-pharmacological treatments. How to treat patients who have an unsatisfactory response to anti-psychotics, including clozapine - which is unequivocally the most powerful antipsychotic medication for this recalcitrant population - remains a clinical conundrum. A range of adjunctive medications have been tried with mixed results; there has also been renewed interest in the role of neuromodulatory strategies, electroconvulsive therapy, and cognitive and vocational approaches. Perhaps a bright spot for the future lies in the evolution of pharmacogenetic approaches for individualized care. In this book, leading experts from Europe, Australia and the Americas provide a timely appraisal of treatments for the most severely ill schizophrenia patients. This clinically focused book is informed by the latest research on the neurobiology and treatment of schizophrenia. It is comprehensive in scope, covering current treatment options, various add-on approaches, and a range of psychosocial treatments. The contributors are respected experts who have combined their clinical experience with cutting-edge research to provide readers with authoritative information on fundamental aspects of clinical care for schizophrenia. |
| clinical practice guidelines for management of schizophrenia: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder American Psychiatric Association, 2018-01-11 Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD. |
| clinical practice guidelines for management of schizophrenia: Clinical Handbook of Schizophrenia Kim Tornvall Mueser, Dilip V. Jeste, 2011-01-31 Reviewing the breadth of current knowledge on schizophrenia, this handbook provides clear, practical guidelines for effective assessment and treatment in diverse contexts. Leading authorities have contributed 61 concise chapters on all aspects of the disorder and its clinical management. In lieu of exhaustive literature reviews, each chapter summarizes the state of the science; highlights key points the busy practitioner needs to know; and lists recommended resources, including seminal research studies, invaluable clinical tools, and more. Comprehensive, authoritative, and timely, the volume will enable professionals in any setting to better understand and help their patients or clients with severe mental illness. |
| clinical practice guidelines for management of schizophrenia: Practice Guideline for the Treatment of Patients with Bipolar Disorder (revision) American Psychiatric Association, 2002 The book provides treatment recommendations for bipolar patients, a review of evidence about bipolar disorder, and states research needs |
| clinical practice guidelines for management of schizophrenia: Antipsychotic Trials in Schizophrenia T. Scott Stroup, Jeffrey A. Lieberman, 2010-04-01 Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading. |
| clinical practice guidelines for management of schizophrenia: Antipsychotic Long-acting Injections Peter Haddad, Tim Lambert, John Lauriello, 2016-05-10 Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon. The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research. Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts. |
| clinical practice guidelines for management of schizophrenia: Personal Therapy for Schizophrenia and Related Disorders Gerard E Hogarty, Msw, This book presents the first evidence-based psychotherapy with demonstrated effectiveness for persons with schizophrenia and related disorders. Designed to help patients both achieve and maintain clinical stability, personal therapy combines psychoeducation; internal coping skills training; and enhancement of interpersonal, social, and vocational functioning. The volume describes how to integrate the approach with medical management and provides a practical, three-phase therapy manual, fully documented with findings from the author's influential research program. Detailed information is presented on the application of graduated strategies as the patient moves from a recent psychotic episode, through the process of optimal stabilization, to the resumption of community life outside the home. Also featured are tools for monitoring progress and suggestions for tailoring interventions to the specific needs of each patient. |
| clinical practice guidelines for management of schizophrenia: Diagnostic and Statistical Manual of Mental Disorders (DSM-5) American Psychiatric Association, 2021-09-24 |
| clinical practice guidelines for management of schizophrenia: Non-Pharmacological Interventions for Schizophrenia: How Much Can Be Achieved and How? Christina Andreou, Christina Andreou, Steffen Moritz, 2017-01-10 The introduction of antipsychotic agents in the 1950’s substantially improved the treatment of schizophrenia and other psychotic disorders. However, clinical and functional outcomes are still far less than optimal for patients, and have not improved in recent years despite the development of several new antipsychotics. Efficacy rates are further compromised by medication non-adherence, which has been reported to affect more than half of patients. In response to these issues, several non-pharmacological interventions have been developed for the treatment of schizophrenia, such as cognitive behavioral therapy, cognitive remediation, social cognition training and metacognitive approaches. Although these interventions have produced promising results, there is still much controversy regarding their usefulness and applicability in clinical practice. A major impeding factor for their dissemination is possibly a lack of sufficient evidence regarding their specific indications, mechanisms of action, adverse effects, but also practical issues concerning the interpretability of respective clinical studies, such as the choice of outcome variables and control of confounding factors. The present Research Topic includes original research articles and reviews addressing these issues. |
| clinical practice guidelines for management of schizophrenia: Medical Illness and Schizophrenia Jonathan M. Meyer, Henry A. Nasrallah, 2009-04-27 Despite growing awareness in the psychiatric community of the multifaceted medical needs of the severely mentally ill, statistics show that as much as 60% of all schizophrenia patients die prematurely from nonpsychiatric medical conditions -- in part because many physicians have not yet recognized how to properly treat common diseases and illnesses within this complex patient population. Medical Illness and Schizophrenia, Second Edition, is the only clinical guide to focus exclusively on the treatment of common medical comorbidities among patients with schizophrenia. Like its best-selling predecessor, the book compiles the latest research and clinical information on integrating medical and psychiatric care for the schizophrenia patient. Twenty-eight physicians and psychiatrists, including editors Jonathan M. Meyer, M.D., and Henry A. Nasrallah, M.D., lend their expertise to this new, expanded edition. In fifteen chapters, this volume covers a wide range of common medical problems -- from metabolic and heart conditions, such as cardiovascular disease, hyperlipidemia, obesity and diabetes, to substance abuse and smoking. Each chapter concludes with Key Clinical Points that summarize important concepts and ensure reader retention. Additionally, the second edition includes new chapters that touch on some of the most complex clinical issues in the field of schizophrenia treatment today: Recent trends in the integration of medical and mental healthcare Behavioral treatments for weight loss in persons with schizophrenia Treatment of sexual dysfunction among persons treated for schizophrenia Health outcomes of schizophrenia treatment in children and adolescents Health outcomes of schizophrenia treatment during pregnancy and breastfeeding As the only clinical text of its kind, Medical Illness and Schizophrenia, Second Edition, is an invaluable resource for psychiatrists, nurses, healthcare professionals, and psychiatric and clinical residents. The goal of this text has always been to help clinicians recognize schizophrenia as both a brain disorder and a systemic disease with multiple manifestations that go beyond the obvious psychiatric symptoms -- and thus take a broader approach to treatment of schizophrenia. This new edition is a comprehensive, practical manual that serves as a reference for the medical management of seriously mentally ill patients across the age spectrum in both inpatient and outpatient settings. |
| clinical practice guidelines for management of schizophrenia: American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders American Psychiatric Association, 2002 Developed by the APA to assist in clinical decision making, the Practice Guidelines series has become an invaluable resource to help benchmark care strategies for 11 common mental disorders. The APA makes Practice Guidelines available to help improve patient care and give members access to the latest information and research. Intended as a professional resource and not a standard of care, the Practice Guidelines provide convenient summaries of what we know about key mental disorders and the effectiveness of specific treatments. The eleven Practice Guidelines are: Alzheimer's Disease and Other Dementias Of Late Life Bipolar Disorder, Second Edition Borderline Personality Disorder Delirium Eating Disorders, Second Edition HIV/AIDS Major Depressive Disorder, Second Edition Panic Disorder Psychiatric Evaluation Of Adults Schizophrenia Substance Use Disorder: Alcohol, Cocaine, Opioids These guidelines help you: Understand clinical features and symptoms Make a confident differential diagnosis Evaluate interventions commonly used to treat specific disorders Select the appropriate site of service Educate the patient and family Assess the efficacy and risks of available medications Develop an individualized treatment plan |
| clinical practice guidelines for management of schizophrenia: The American Psychiatric Association Publishing Textbook of Schizophrenia, Second Edition Jeffrey A. Lieberman, M.D., T. Scott Stroup, M.D., M.P.H., Diana O. Perkins, M.D., M.P.H., Lisa B. Dixon, M.D., M.P.H., 2020-01-30 Schizophrenia remains the most challenging of mental disorders confronted by psychiatrists and other mental health providers. Its primary manifestations-psychotic symptoms and cognitive impairment-profoundly affect the functioning of individuals with schizophrenia. This is an updated textbook covering the current state of knowledge about schizophrenia, including its causes, nature, presentation, and treatment. Chapters are written by a roster of experts in -- |
| clinical practice guidelines for management of schizophrenia: The Social Determinants of Mental Health Michael T. Compton, Ruth S. Shim, 2015-04-01 The Social Determinants of Mental Health aims to fill the gap that exists in the psychiatric, scholarly, and policy-related literature on the social determinants of mental health: those factors stemming from where we learn, play, live, work, and age that impact our overall mental health and well-being. The editors and an impressive roster of chapter authors from diverse scholarly backgrounds provide detailed information on topics such as discrimination and social exclusion; adverse early life experiences; poor education; unemployment, underemployment, and job insecurity; income inequality, poverty, and neighborhood deprivation; food insecurity; poor housing quality and housing instability; adverse features of the built environment; and poor access to mental health care. This thought-provoking book offers many beneficial features for clinicians and public health professionals: Clinical vignettes are included, designed to make the content accessible to readers who are primarily clinicians and also to demonstrate the practical, individual-level applicability of the subject matter for those who typically work at the public health, population, and/or policy level. Policy implications are discussed throughout, designed to make the content accessible to readers who work primarily at the public health or population level and also to demonstrate the policy relevance of the subject matter for those who typically work at the clinical level. All chapters include five to six key points that focus on the most important content, helping to both prepare the reader with a brief overview of the chapter's main points and reinforce the take-away messages afterward. In addition to the main body of the book, which focuses on selected individual social determinants of mental health, the volume includes an in-depth overview that summarizes the editors' and their colleagues' conceptualization, as well as a final chapter coauthored by Dr. David Satcher, 16th Surgeon General of the United States, that serves as a Call to Action, offering specific actions that can be taken by both clinicians and policymakers to address the social determinants of mental health. The editors have succeeded in the difficult task of balancing the individual/clinical/patient perspective and the population/public health/community point of view, while underscoring the need for both groups to work in a unified way to address the inequities in twenty-first century America. The Social Determinants of Mental Health gives readers the tools to understand and act to improve mental health and reduce risk for mental illnesses for individuals and communities. Students preparing for the Medical College Admission Test (MCAT) will also benefit from this book, as the MCAT in 2015 will test applicants' knowledge of social determinants of health. The social determinants of mental health are not distinct from the social determinants of physical health, although they deserve special emphasis given the prevalence and burden of poor mental health. |
| clinical practice guidelines for management of schizophrenia: CBT for Psychosis Roger Hagen, Douglas Turkington, Torkil Berge, Rolf W. Gråwe, 2013-09-05 This book offers a new approach to understanding and treating psychotic symptoms using Cognitive Behavioural Therapy (CBT). CBT for Psychosis shows how this approach clears the way for a shift away from a biological understanding and towards a psychological understanding of psychosis. Stressing the important connection between mental illness and mental health, further topics of discussion include: the assessment and formulation of psychotic symptoms how to treat psychotic symptoms using CBT CBT for specific and co-morbid conditions CBT of bipolar disorders. This book brings together international experts from different aspects of this fast developing field and will be of great interest to all mental health professionals working with people suffering from psychotic symptoms. |
| clinical practice guidelines for management of schizophrenia: A Guide to Assessments that Work John Hunsley, Eric J. Mash, 2018 This volume addresses the assessment of the most commonly encountered disorders or conditions among children, adolescents, adults, older adults, and couples. Strategies and instruments for assessing mood disorders, anxiety and related disorders, couple distress and sexual problems, health-related problems, and many other conditions are reviewed by leading experts. |
| clinical practice guidelines for management of schizophrenia: Psychoeducation Manual for Bipolar Disorder Francesc Colom, Eduard Vieta, 2006-10-05 Although the mainstay of bipolar therapy is drug treatment, psychoeducation is a technique that has proven to be very effective as an add-on to medication, helping to reduce the number of all types of bipolar recurrences and hospitalisation. The object is to improve patients' understanding of the disorder and therefore their adherence to pharmacotherapy. Based on the highly successful, evidence-based Barcelona program, this book is a pragmatic, therapists' guide for how to implement psychoeducation for bipolar patients. It gives practical guidance for how to conduct a psychoeducation group, using sessions and cases drawn from the Barcelona Psychoeducation Program. Moreover, it provides the reader with a great amount of practical tips and tricks and specific techniques to maximize the benefits of bipolar psychoeducation. The authors formed the first group to show the efficacy of psychoeducation as a maintenance treatment and have a long history of performing bipolar psychoeducation. |
| clinical practice guidelines for management of schizophrenia: The Maudsley Prescribing Guidelines in Psychiatry David M. Taylor, Thomas R. E. Barnes, Allan H. Young, 2018-07-16 The revised 13th edition of the essential reference for the prescribing of drugs for patients with mental health disorders The revised and updated 13th edition of The Maudsley Prescribing Guidelines in Psychiatry provides up-to-date information, expert guidance on prescribing practice in mental health, including drug choice, treatment of adverse effects and how to augment or switch medications. The text covers a wide range of topics including pharmacological interventions for schizophrenia, bipolar disorder, depression and anxiety, and many other less common conditions. There is advice on prescribing in children and adolescents, in substance misuse and in special patient groups. This world-renowned guide has been written in concise terms by an expert team of psychiatrists and specialist pharmacists. The Guidelines help with complex prescribing problems and include information on prescribing psychotropic medications outside their licensed indications as well as potential interactions with other medications and substances such as alcohol, tobacco and caffeine. In addition, each of the book’s 165 sections features a full reference list so that evidence on which guidance is based can be readily accessed. This important text: Is the world’s leading clinical resource for evidence-based prescribing in day-to-day clinical practice and for formulating prescribing policy Includes referenced information on topics such as transferring from one medication to another, prescribing psychotropic medications during pregnancy or breastfeeding, and treating patients with comorbid physical conditions, including impaired renal or hepatic function. Presents guidance on complex clinical problems that may not be encountered routinely Written for psychiatrists, neuropharmacologists, pharmacists and clinical psychologists as well as nurses and medical trainees, The Maudsley Prescribing Guidelines in Psychiatry are the established reference source for ensuring the safe and effective use of medications for patients presenting with mental health problems. |
| clinical practice guidelines for management of schizophrenia: The Epidemiology of Schizophrenia Robin M. Murray, Peter B. Jones, Ezra Susser, Jim Van Os, Mary Cannon, 2009-10-01 An international team of leading researchers and clinicians provides the first comprehensive, epidemiological overview of this multi-faceted and still-perplexing disorder. Controversial issues such as the validity of discrete or dimensional classifications of schizophrenia and the continuum between psychosis and 'normality' are explored in depth. Separate chapters are devoted to topics of particular relevance to schizophrenia such as suicide, violence and substance abuse. Finally, new prospects for treatment and prevention are considered. |
| clinical practice guidelines for management of schizophrenia: Evaluation of the Department of Veterans Affairs Mental Health Services National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Committee to Evaluate the Department of Veterans Affairs Mental Health Services, 2018-03-29 Approximately 4 million U.S. service members took part in the wars in Afghanistan and Iraq. Shortly after troops started returning from their deployments, some active-duty service members and veterans began experiencing mental health problems. Given the stressors associated with war, it is not surprising that some service members developed such mental health conditions as posttraumatic stress disorder, depression, and substance use disorder. Subsequent epidemiologic studies conducted on military and veteran populations that served in the operations in Afghanistan and Iraq provided scientific evidence that those who fought were in fact being diagnosed with mental illnesses and experiencing mental healthâ€related outcomesâ€in particular, suicideâ€at a higher rate than the general population. This report provides a comprehensive assessment of the quality, capacity, and access to mental health care services for veterans who served in the Armed Forces in Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn. It includes an analysis of not only the quality and capacity of mental health care services within the Department of Veterans Affairs, but also barriers faced by patients in utilizing those services. |
| clinical practice guidelines for management of schizophrenia: Schizophrenia Into Later Life Carl I. Cohen, 2003 Over the next 30 years, the number of chronically mentally ill people 55 years of age and older will double. With multiple disorders relating to mental illness and old age, this population will require unique services from a health care system that is ill prepared to deliver them. This is the first major multidisciplinary reference on this important topic. Coverage includes information on demographic and clinical characteristics of older schizophrenic persons, treatment approaches, research strategies, and economic and health policy issues. |
| clinical practice guidelines for management of schizophrenia: Managing Negative Symptoms of Schizophrenia István Bitter, 2020-04-09 Schizophrenia is one of the most severe psychiatric disorders, carrying with it significant stigma and a number of debilitating symptoms. While material on its positive symptoms, such as hallucinations and delusions, is readily available, its negative symptoms, which present heterogeneously as deficits across a variety of domains, are not nearly so well-documented and often go undiagnosed with no effective treatment. Given the poor functioning and outcomes which occur as a result of these symptoms, it is imperative they receive greater focus. Part of the Oxford Psychiatry Library (OPL) series, this concise pocketbook provides readers with a comprehensive overview of the definition, evaluation, and treatment of negative symptoms. Written by experts in the field, with key points at the beginning of each chapter for quick reference, this is an invaluable resource for any mental health care professional working with individuals affected by schizophrenia. |
| clinical practice guidelines for management of schizophrenia: Camberwell Assessment of Need: Forensic Version Stuart Thomas, Mike Slade, 2021-04-29 The Camberwell Assessment of Need Forensic Version (CANFOR) is a tool for assessing the needs of people with mental health problems who are in contact with forensic services. It is based on the CAN, a widely used needs assessment for people with severe mental health problems. Individual needs are assessed in 25 areas of life, spanning health, social, clinical and functional domains. Comprehensive versions are available for research (CANFOR-R) and clinical use (CANFOR-C), as well as a short summary version (CANFOR-S) suitable for both research and clinical use. CANFOR was rigorously developed by a multidisciplinary team at the Institute of Psychiatry, London, and is suitable for use in all forensic mental health and prison settings. This second edition provides an update of the CANFOR tools and their application in clinical and research settings. The assessment forms are freely available to download from the CAN website (researchintorecovery.com/can) and cambridge.org. |
| clinical practice guidelines for management of schizophrenia: A Report on Mental Illnesses in Canada Canada. Health Canada, 2002 This report is designed to raise the profile of mental illness in Canada among government & non-governmental organizations and the industry, education, workplace, & academic sectors. It describes major mental illnesses and outlines their incidence & prevalence, causation, impact, stigma, and prevention & treatment. Data presented are based on currently available provincial studies & data on mortality and hospitalizations. Five mental illnesses have been selected for inclusion in the report by virtue of their high prevalence rates or because of the magnitude of their health, social, & economic impact: mood disorders, schizophrenia, anxiety disorders, personality disorders, and eating disorders. While not in itself a mental illness, suicidal behaviour is also included since it is highly correlated with mental illness and raises many similar issues. The appendix includes information on data sources and a call for action on building consensus for a national action plan on mental illness & mental health. |
| clinical practice guidelines for management of schizophrenia: The Early Course of Schizophrenia Tonmoy Sharma, Philip D. Harvey, 2006-02-23 New developments in the basic and clinical neurosciences have lead to important advances in our understanding of the events that occur between conception and birth that can influence schizophrenia. At the other end of the life span, some of the most exciting developments in years have recently been coming out of post-mortem studies of patients with schizophrenia. This volume is unique in adopting a lifespan approach to understanding schizophrenia. With contributions from leading scientists in this field, and research from the frontiers of schizophrenia research, the book demonstrates the practical applications of this knowledge in developing new and effective treatments. This volume is a major new addition to the psychiatry literature. |
| clinical practice guidelines for management of schizophrenia: Schizophrenia Debbie Ernest, Olga Vuksic, Ashley Shepard-Smith, 2017-09 This guide for people with schizophrenia and their families discusses symptoms, causes and treatment of schizophrenia, and how family members can support the person with schizophrenia and take care of themselves. |
| clinical practice guidelines for management of schizophrenia: Making Health Care Safer , 2001 This project aimed to collect and critically review the existing evidence on practices relevant to improving patient safety--P. v. |
| clinical practice guidelines for management of schizophrenia: The UKU Side Effect Rating Scale O. Lingjaerde, 1987 |
| clinical practice guidelines for management of schizophrenia: Clinical Practice Guideline for the Management of Borderline Personality Disorder National Health and Medical Research Council, 2013-02-14 |
| clinical practice guidelines for management of schizophrenia: Practice Guideline for the Treatment of Patients with Eating Disorders American Psychiatric Association, 2000 The care of patients with eating disorders involves a comprehensive array of approaches. These guidelines contain the clinical factors that need to be considered when treating a patient with anorexia nervosa or bulimia nervosa. |
| clinical practice guidelines for management of schizophrenia: Problem-Solving Therapy Thomas D'Zurilla, PhD, Arthur M. Nezu, PhD, ABPP, 2006-09-18 MAXIMIZE POSITIVE PATIENT OUTCOMES Enhance Function--Avert Relapses--Present New Problems In this new updated edition, authors Thomas J. D'Zurilla and Arthur M. Nezu, present some of the most useful advances in problem-solving therapy (PST) today. An excellent resource for maximizing positive patient outcomes, this all-inclusive guide helps enhance your problem solving skills and apply successful clinical techniques to help your clients improve their lives. Known for its presentation of solid research results and effective PST training tools, this best-selling guide has been fully updated to include: NEW research data on social problem solving and adjustment NEW studies on the efficacy of PST NEW social problem solving models NEW updated and more user-friendly therapist's training manual Written for a wide audience, from therapists and counselors to psychologists and social workers, this highly readable and practical reference is a must-have guide to helping your patients identify and resolve current life problems. The book set is designed to be read alongside its informal manual accompaniment, Solving Life's Problems: A 5-Step Guide to Enhanced Well-Being by D'Zurilla, Nezu, and Christine Maguth Nezu. Purchase of the two books as a set will get you these life-changing texts at an $7.00 savings over the two books bought individually. |
| clinical practice guidelines for management of schizophrenia: The American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia, Third Edition American Psychiatric Association, 2020-09-04 The goal of this practice guideline is to improve the quality of care and treatment outcomes for patients with schizophrenia. The guideline aims to help clinicians optimize care for their patients by providing evidence-based statements that are intended to enhance knowledge and increase the appropriate use of evidence-based pharmacological and nonpharmacological treatments for schizophrenia. In addition, it includes statements related to assessment and treatment planning, which are an integral part of patient-centered care-- |
| clinical practice guidelines for management of schizophrenia: Clinical Practice Guidelines in Mental Health Paula Whitty, Martin Eccles, 2018-12-14 This book describes the user-focused action evaluation approach for evaluating health programmes policies and changes. It shows that evidence for making decisions can be gathered using a broader range of methods than is usually recognised in healthcare. In asking 'evaluation for whom and for what?' the book defines validity of evidence in relation to usefulness as well as in terms of whether systematic methods were followed. Managers practitioners policy makers researchers and students will find this a practical and readable book. It gives the tools to make sense of an evaluation quickly as well as guidance for carrying one out and ensuring that evaluators gather evidence which can be used for better informed decisions. |
| clinical practice guidelines for management of schizophrenia: Advancing Frontiers of Psychiatric Therapeutics P K Singh, 2020-05-31 |
Clinical Practice Guidelines for Management of Schizophrenia
In 2005, the Indian Psychiatric Society came up with treatment guidelines for schizophrenia tailored to meet the requirements of our patients in the context of prevailing existing resources. …
THE AMERICAN PSYCHIATRIC ASSOCIATION PRACTICE …
Statement 1: Assessment of Possible Schizophrenia .....18 Implementation .....18
Royal Australian and New Zealand College of Psychiatrists …
Results: The clinical practice guideline for the management of schizophrenia and related disorders reflects an increasing emphasis on early intervention, physical health, psychosocial …
VA/DoD Clinical Practice Guideline for the Management of …
The evidence-based clinical practice recommendations listed (see Table 1) were made using a systematic approach considering four domains as per the GRADE approach (see Methods …
MANAGEMENT OF SCHIZOPHRENIA - Ministry of Health
• Practice Guideline for The Treatment of Patients with Schizophrenia (Third Edition) [The American Psychiatric Association (APA), 2019] • Psychosis and Schizophrenia in Adults …
The American Psychiatric Association practice guideline for …
direction on implementing these recommendations into clinical practice, with the goal of improving the quality of care and treatment outcomes for patients with schizophrenia.
APA PRACTICE GUIDELINE TREATMENT OF SCHIZOPHRENIA
APA recommends (1C) that patients with schizophrenia have a documented, comprehensive, and person-centered treatment plan that includes evidence-based nonpharmacological and …
PRACTICE GUIDELINE FOR THE Treatment of Patients With …
The Practice Guideline for the Treatment of Patients With Schizophrenia, Second Edition, consists of three parts (Parts A, B, and C) and many sections, not all of which will be equally useful for …
CLINICAL PRACTICE GUIDELINES Pharmacologic Treatment of …
May 1, 2025 · CBH has updated its guidelines for the treatment of schizophrenia to reflect the published evidence-based practice parameters of the American Psychiatric Association issued …
VA/DoD Clinical Practice Guidelines
VA/DoD Clinical Practice Guideline for Management of First-Episode Psychosis and Schizophrenia – Quick Reference Guide April 2023 Page 9 of 9 Abbreviations: ECT: …
Schizophrenia Clinical Guideline - mvphealthcare.com
MVP adopted the APA guideline which offers practitioners and patients evidence-based treatment options for individuals who suffer with schizophrenia. The guideline begins with an assessment …
MANAGEMENT OF SCHIZOPHRENIA IN ADULTS - Ministry of …
This CPG was adapted from Schizophrenia Clinical Guideline on core interventions in primary and secondary care (National Collaborating Centre for Mental Health/National Institute for Clinical …
Practice Guidelines - AAFP
Early intervention, family therapy, and supported employment services are important elements of care for first-episode psychosis. Schizophrenia is best managed in assertive commu-nity care …
Clinical Practice Guidelines for the Management of …
Schizophrenia is understood as a chronic disabling condition, which has a significant negative impact on the life of a patient and their family. When the onset of illness for schizophrenia is …
Psychosocial Management of First-Episode Psychosis and …
Congress to require the development of clinical practice guide - lines (CPG) for the treatment of schizophrenia. This paper re - ports on the psychosocial and rehabilitative recommendations …
The American Psychiatric Association Practice Guideline for …
at APA’s Practice Guidelines website. The goal of this guideline is to improve the quality of care and treatment outcomes for patients with schizophrenia, as defined by the Diagnostic and …
VA/DoD Clinical Practice Guideline (CPG) for the Management …
VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF FIRST-EPISODE PSYCHOSIS AND SCHIZOPHRENIA Department of Veterans Affairs Department of Defense …
MANAGEMENT OF SCHIZOPHRENIA IN ADULTS QUICK …
MANAGEMENT OF SCHIZOPHRENIA IN ADULTS QUICK REFERENCE FOR HEALTH CARE PROVIDERS 1 KEY MESSAGES l Schizophrenia is a major psychiatric disorder that alters an …
VA/DoD Clinical Practice Guideline (CPG) for the Management …
VA/DoD Clinical Practice Guideline for Management of First-Episode Psychosis and Schizophrenia April 2023 Page 5 of 231 . I. Introduction . The VA and DoD Evidence-Based …
The American Psychiatric Association Practice Guideline for …
At its December 2019 meeting, the American Psychiatric Association (APA) Board of Trustees approved “The Amer-ican Psychiatric Association Practice Guideline for the Treatment of …
Clinical Practice Guidelines for Management of …
In 2005, the Indian Psychiatric Society came up with treatment guidelines for schizophrenia tailored to meet the requirements of our patients in the context of prevailing existing resources. …
THE AMERICAN PSYCHIATRIC ASSOCIATION PRACTICE …
Statement 1: Assessment of Possible Schizophrenia .....18 Implementation .....18
Royal Australian and New Zealand College of Psychiatrists …
Results: The clinical practice guideline for the management of schizophrenia and related disorders reflects an increasing emphasis on early intervention, physical health, psychosocial …
VA/DoD Clinical Practice Guideline for the Management of …
The evidence-based clinical practice recommendations listed (see Table 1) were made using a systematic approach considering four domains as per the GRADE approach (see Methods …
MANAGEMENT OF SCHIZOPHRENIA - Ministry of Health
• Practice Guideline for The Treatment of Patients with Schizophrenia (Third Edition) [The American Psychiatric Association (APA), 2019] • Psychosis and Schizophrenia in Adults …
The American Psychiatric Association practice guideline for …
direction on implementing these recommendations into clinical practice, with the goal of improving the quality of care and treatment outcomes for patients with schizophrenia.
APA PRACTICE GUIDELINE TREATMENT OF SCHIZOPHRENIA
APA recommends (1C) that patients with schizophrenia have a documented, comprehensive, and person-centered treatment plan that includes evidence-based nonpharmacological and …
PRACTICE GUIDELINE FOR THE Treatment of Patients With …
The Practice Guideline for the Treatment of Patients With Schizophrenia, Second Edition, consists of three parts (Parts A, B, and C) and many sections, not all of which will be equally useful for …
CLINICAL PRACTICE GUIDELINES Pharmacologic Treatment …
May 1, 2025 · CBH has updated its guidelines for the treatment of schizophrenia to reflect the published evidence-based practice parameters of the American Psychiatric Association issued …
VA/DoD Clinical Practice Guidelines
VA/DoD Clinical Practice Guideline for Management of First-Episode Psychosis and Schizophrenia – Quick Reference Guide April 2023 Page 9 of 9 Abbreviations: ECT: …
Schizophrenia Clinical Guideline - mvphealthcare.com
MVP adopted the APA guideline which offers practitioners and patients evidence-based treatment options for individuals who suffer with schizophrenia. The guideline begins with an assessment …
MANAGEMENT OF SCHIZOPHRENIA IN ADULTS - Ministry …
This CPG was adapted from Schizophrenia Clinical Guideline on core interventions in primary and secondary care (National Collaborating Centre for Mental Health/National Institute for Clinical …
Practice Guidelines - AAFP
Early intervention, family therapy, and supported employment services are important elements of care for first-episode psychosis. Schizophrenia is best managed in assertive commu-nity care …
Clinical Practice Guidelines for the Management of …
Schizophrenia is understood as a chronic disabling condition, which has a significant negative impact on the life of a patient and their family. When the onset of illness for schizophrenia is …
Psychosocial Management of First-Episode Psychosis and …
Congress to require the development of clinical practice guide - lines (CPG) for the treatment of schizophrenia. This paper re - ports on the psychosocial and rehabilitative recommendations …
The American Psychiatric Association Practice Guideline for …
at APA’s Practice Guidelines website. The goal of this guideline is to improve the quality of care and treatment outcomes for patients with schizophrenia, as defined by the Diagnostic and …
VA/DoD Clinical Practice Guideline (CPG) for the …
VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF FIRST-EPISODE PSYCHOSIS AND SCHIZOPHRENIA Department of Veterans Affairs Department of Defense …
MANAGEMENT OF SCHIZOPHRENIA IN ADULTS QUICK …
MANAGEMENT OF SCHIZOPHRENIA IN ADULTS QUICK REFERENCE FOR HEALTH CARE PROVIDERS 1 KEY MESSAGES l Schizophrenia is a major psychiatric disorder that alters an …
VA/DoD Clinical Practice Guideline (CPG) for the …
VA/DoD Clinical Practice Guideline for Management of First-Episode Psychosis and Schizophrenia April 2023 Page 5 of 231 . I. Introduction . The VA and DoD Evidence-Based …
The American Psychiatric Association Practice Guideline for …
At its December 2019 meeting, the American Psychiatric Association (APA) Board of Trustees approved “The Amer-ican Psychiatric Association Practice Guideline for the Treatment of …
